Drug-induced alzheimerism.

Area of Science:

• Neurology
• Geriatrics
• Pharmacology

Background:

• Parkinsonism is a neurological disorder affecting motor control.
• Cognitive and behavioral dysfunction can occur in parkinsonism, sometimes resembling Alzheimer's disease.
• Anticholinergic medications are frequently used to manage parkinsonian symptoms.

Observation:

• A 74-year-old male patient with parkinsonism exhibited progressive cognitive and behavioral decline.
• These neurological impairments were initially suspected to be indicative of coexistent Alzheimer's disease.
• The patient was receiving anticholinergic antiparkinsonian medication.

Findings:

• Withdrawal of the anticholinergic medication led to a reversal of the patient's cognitive and behavioral disturbances.
• This case highlights that anticholinergic drugs may mimic or exacerbate Alzheimer's-like symptoms in parkinsonism patients.
• The findings suggest a potential drug-induced etiology for the observed cognitive and behavioral dysfunction.

Implications:

• Anticholinergic medications should be carefully considered in parkinsonism patients presenting with cognitive or behavioral impairments.
• Discontinuation of these drugs may be beneficial for parkinsonian patients experiencing significant cognitive or behavioral decline.
• Further research is warranted to understand the impact of anticholinergic burden on cognition in neurodegenerative diseases.